Analysis of an outbreak of Clostridium difficile infection controlled with enhanced infection control measures

BackgroundIn October 2004, our Clostridium difficile infection (CDI) rate increased (relative risk, 3.51; 95% confidence interval: 2.96-4.16) from a baseline rate of 1.35 per 1000 patient-days. We describe the outbreak, the relationship between antibiotic use and CDI, and the effect of enhanced infection control measures (EICM) on CDI.MethodsRates were calculated as positive C difficile toxin A or B tests among patients with nosocomial diarrhea per 1000 patient-days (duplicates removed). Antibiotic use was calculated as defined daily dose per 1000 patient-days. EICM consisted of (1) placing patients with diarrhea into empiric Contact Precautions, (2) cleaning with a bleach product in areas with CDI patients, and (3) requiring soap and water hand hygiene when caring for CDI patients. CDI rates were analyzed by χ2 for trend. Time series methodology was used to examine the association between CDI and antibiotic use.ResultsDuring the outbreak (October 2004-May 2005), we observed 144 excess cases of CDI. The CDI rate decreased after EICM were implemented (P < .0001) and has been maintained for 36 months beyond the outbreak. Multivariate analysis revealed positive associations between CDI rates and cefazolin use (P = .008) and levofloxacin/gatifloxacin use (P = .015).ConclusionDespite an association between some antibiotic use and CDI rates, we achieved sustained control of an outbreak using EICM without formulary changes or new antibiotic control policies. This suggests that patient-to-patient spread may be a more important cause of increased CDI rates.